Trials / Completed
CompletedNCT05351944
Dialectical Behavioral Therapy Skills for Impulsive Aggression
Dialectical Behavioral Therapy Skills for Impulsive Aggression in Children Diagnosed with Attention Deficit Hyperactivity Disorder At Alexandria University Hospitals
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 66 (actual)
- Sponsor
- Alexandria University · Academic / Other
- Sex
- Male
- Age
- 6 Years – 13 Years
- Healthy volunteers
- Not accepted
Summary
This trial aims to Study the efficacy of DBT skills for impulsive aggression and executive dysfunctions in drug naïve children who are presented with impulsive aggression and ADHD and attending Child and adolescent clinic at Alexandria university hospitals using weekly group therapy for 8 month and testing pre and posttreatment biomarkers of aggression.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Dialectical behavioral therapy skills for the intervention experimental group A | Our hypothesis is that impulsive aggression as evidenced by inflammatory biomarkers might improve by targeting executive dysfunctions with Dialectical Behavioural Therapy skills modules directed to the children and their parents in the form of response inhibition dysfunctions with Dialectical Behavioural Therapy mindfulness and distress tolerance skills modules, emotion regulation executive dysfunctions with Dialectical Behavioural Therapy emotion regulation skills module and socioenvironmental factors with interpersonal effectiveness and walking the middle path Dialectical behavioural therapy skills modules. |
| DRUG | psychoeducation or Atomoxetine or stimulants according to ADHD severity | the control group (group B) will receive psychoeducation and medications targeting ADHD symptoms (Atomoxetine or stimulants according to FDA approved dose according to age and weight ) according to the international guidelines for management of ADHD according to symptom severity |
Timeline
- Start date
- 2023-05-07
- Primary completion
- 2024-01-21
- Completion
- 2024-05-18
- First posted
- 2022-04-28
- Last updated
- 2024-09-19
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05351944. Inclusion in this directory is not an endorsement.